Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04615260 · ClinicalTrials.gov registry record · NA
Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.
A NA study of Degenerative Disc Disease and Spondylolisthesis, sponsored by Artoss.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04615260 is a NA study of Degenerative Disc Disease and Spondylolisthesis that is active but no longer recruiting, run by Artoss. The registered enrollment target is 40 participants, below the 168-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04615260, a NA study of Degenerative Disc Disease and Spondylolisthesis, is active but no longer recruiting, sponsored by Artoss.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of this longitudinal study are to assess and measure fusion status (fused or not fused) and rate of bony fusion using NanoBone® Synthetic Bone Graft in patients requiring one to two level lumbar posterolateral fusion procedures with or without commercially available rigid spinal instrumentation. Our hypothesis is that the Nanobone synthetic bone graft will be as effective at creating a fusion in the lumbar spine as compared with a local bone graft. Each subject will serve as their own control during this study, as patients will receive the Nanobone graft on the right side of their spine and the local bone graft on their left side.
Conditions Studied
Interventions
- DEVICE NanoBone
Study Locations (1)
Massachusetts
- UMass Memorial Health Care - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-07-19 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04615260
The ClinicalTrials.gov registry entry for NCT04615260 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 168-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (76% lower). The listed sponsor is Artoss, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which NanoBone is the first listed.
NCT04615260 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04615260 about?
NCT04615260 is a clinical study titled "Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.". The objectives of this longitudinal study are to assess and measure fusion status (fused or not fused) and rate of bony fusion using NanoBone® Synthetic Bone Graft in patients requiring one to two level lumbar posterolateral fusion procedures with or without commercially available rigid spinal instr...
What is the current status of trial NCT04615260?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2021-07-19. Estimated completion is 2025-04-30.
What conditions does trial NCT04615260 study?
This clinical trial studies the following conditions: Degenerative Disc Disease, Spondylolisthesis.
What interventions are being tested in trial NCT04615260?
The interventions under investigation include: NanoBone (DEVICE).
Who is sponsoring clinical trial NCT04615260?
This trial is sponsored by Artoss, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04615260 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
-
Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.
RECRUITING · NA
-
MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion
RECRUITING · NA
-
ACDF Using Structural Allograft vs. Tritanium C
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.